Rath Susann, Schepmann Dirk, Wünsch Bernhard
Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraβe 48, D-48149 Münster, Germany.
Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraβe 48, D-48149 Münster, Germany; Cells-in-Motion Cluster of Excellence (EXC 1003 - CiM), Westfälische Wilhelms-Universität Münster, Germany.
Bioorg Med Chem. 2017 Oct 15;25(20):5365-5372. doi: 10.1016/j.bmc.2017.07.059. Epub 2017 Jul 29.
Since overactivation of NMDA receptors is associated with neurodegenerative disorders, the design and development of subunit-selective NMDA receptor antagonists are of great interest. In order to avoid the formation of quinone-like intermediates as starting point for degradation the benzylic OH group of the lead compounds 2 was replaced by an electron rich vinyl or homologous hydroxymethyl moiety. The Bi(OTf) catalyzed intramolecular Friedel-Crafts alkylation of 9a represents the key step in the synthesis of 1-vinyl substituted tetrahydro-3-benzazepine 10. Ozonolysis of 10 and subsequent reduction led to the hydroxymethyl derivative 14. The GluN2B affinities of the methyl ethers 2a, 3a and 4a and phenols 2b and 3b are very similar, respectively. It can be concluded that the ifenprodil binding site of GluN2B subunit containing NMDA receptors well tolerates a vinyl or hydroxymethyl moiety instead of the benzylic OH group. However, the selectivity has to improved, since the σ affinity of the new ligands is higher than their GluN2B affinity.
由于NMDA受体的过度激活与神经退行性疾病相关,亚基选择性NMDA受体拮抗剂的设计与开发备受关注。为避免醌类中间体的形成作为降解的起始点,先导化合物2的苄基OH基团被富电子的乙烯基或同系羟甲基部分取代。9a的Bi(OTf)催化分子内傅克烷基化反应是合成1-乙烯基取代四氢-3-苯并氮杂䓬10的关键步骤。10的臭氧分解及随后的还原反应得到羟甲基衍生物14。甲基醚2a、3a和4a以及酚类2b和3b的GluN2B亲和力分别非常相似。可以得出结论,含GluN2B亚基的NMDA受体的ifenprodil结合位点能够很好地耐受乙烯基或羟甲基部分而非苄基OH基团。然而,由于新配体的σ亲和力高于它们的GluN2B亲和力,选择性还有待提高。